In upper airway samples and blood leukocytes of SARS‐CoV‐2‐infected patients, it has been reported that EPSTI1 is significantly overexpressed compared to patients without SARS‐CoV‐2 infection, and could have a helpful effect on antiviral therapy in COVID-19 [27]. Here, EPSTI1 is linked to COVID-19.